138 related articles for article (PubMed ID: 36656541)
1. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
[TBL] [Abstract][Full Text] [Related]
3. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
[TBL] [Abstract][Full Text] [Related]
5. Assessment of inflammatory jaw pathologies using bone SPECT/CT maximum standardized uptake value.
Toshima H; Ogura I
Dentomaxillofac Radiol; 2020 Dec; 49(8):20200043. PubMed ID: 32491931
[TBL] [Abstract][Full Text] [Related]
6. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
[TBL] [Abstract][Full Text] [Related]
7. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
Tezuka Y; Ogura I
Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
[TBL] [Abstract][Full Text] [Related]
8. Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
Minami Y; Ogura I
Nucl Med Commun; 2022 Dec; 43(12):1188-1194. PubMed ID: 36345763
[TBL] [Abstract][Full Text] [Related]
9. Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.
Ogawa R; Ogura I
Dentomaxillofac Radiol; 2021 Dec; 50(8):20200516. PubMed ID: 34019434
[TBL] [Abstract][Full Text] [Related]
10. Quantitative [
Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
[TBL] [Abstract][Full Text] [Related]
11. Quantification evaluation of
Huang K; Feng Y; Liu D; Liang W; Li L
Ann Nucl Med; 2020 Feb; 34(2):136-143. PubMed ID: 31768820
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
Motegi K; Matsutomo N; Yamamoto T; Koizumi M
Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
[TBL] [Abstract][Full Text] [Related]
13. Quantitative bone SPECT/CT applications for primary bone neoplasms.
Kitajima K; Futani H; Komoto H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
Hell J Nucl Med; 2021; 24(1):36-44. PubMed ID: 33866337
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
An YS; Park DY; Min BH; Lee SJ; Yoon JK
BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions in Diagnosing Medication-related Osteonecrosis of the Jaw.
Beck MT; Rugel G; Reinfelder J; Kuwert T; Ritt P; Kreissel S; Schlittenbauer T
Nuklearmedizin; 2021 Dec; 60(6):403-410. PubMed ID: 34380154
[TBL] [Abstract][Full Text] [Related]
16. Comparison of single photon emission computed tomography-computed tomography, computed tomography and magnetic resonance imaging of osteonecrosis of jaw by new calculated parameters.
Minami Y; Ogura I
Q J Nucl Med Mol Imaging; 2022 Oct; ():. PubMed ID: 36287042
[TBL] [Abstract][Full Text] [Related]
17. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
Dore F; Filippi L; Biasotto M; Chiandussi S; Cavalli F; Di Lenarda R
J Nucl Med; 2009 Jan; 50(1):30-5. PubMed ID: 19091894
[TBL] [Abstract][Full Text] [Related]
18. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
19. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
Hata H; Kitao T; Sato J; Asaka T; Ohga N; Imamachi K; Hirata K; Shiga T; Yamazaki Y; Kitagawa Y
Sci Rep; 2020 Jul; 10(1):11385. PubMed ID: 32647190
[TBL] [Abstract][Full Text] [Related]
20. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.
Bando R; Otsuka H; Otani T; Matsuda N; Azane S; Kunikane Y; Otomi Y; Sako W; Izumi Y; Harada M
Ann Nucl Med; 2021 Apr; 35(4):504-513. PubMed ID: 33630226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]